Edgewise Therapeutics, Inc. (NASDAQ: EWTX)
$27.9500
+0.9200 ( +3.06% ) 307.0K
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.
Market Data
Open
$27.9500
Previous close
$27.0300
Volume
307.0K
Market cap
$2.60B
Day range
$27.0100 - $28.2690
52 week range
$9.0000 - $38.1200
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jun 12, 2024 |
| 4 | Insider transactions | 1 | Jun 12, 2024 |
| 4 | Insider transactions | 1 | Jun 12, 2024 |
| 4 | Insider transactions | 2 | Jun 12, 2024 |
| 4 | Insider transactions | 1 | Jun 12, 2024 |
| 4 | Insider transactions | 1 | Jun 12, 2024 |
| 8-k | 8K-related | 14 | Jun 11, 2024 |
| 8-k | 8K-related | 14 | May 10, 2024 |
| 10-q | Quarterly Reports | 57 | May 09, 2024 |
| 8-k | 8K-related | 15 | May 09, 2024 |